•
Sep 30, 2021

ImmunityBio Q3 2021 Earnings Report

Total Revenue
$66K
Previous year: $151K
-56.3%
EPS
-$0.22
Previous year: -$0.41
-46.3%
Gross Profit
$66K
Previous year: $151K
-56.3%
Cash and Equivalents
$64.5M
Previous year: $84.7M
-23.8%
Free Cash Flow
-$80.7M
Previous year: -$20M
+304.2%
Total Assets
$214M
Previous year: $181M
+18.8%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment